23 September 2021 12:42ZICCUM’S NEW DEVELOPMENT DIRECTOR ON A PIVOTAL PHASE FOR THE COMPANY
With a range of research collaboration projects ongoing at its lab in Lund, all running in parallel with continuing work on developing LaminarPace for GMP industrial production, Ziccum’s new Development Director Anna Lönn faces a demanding...
26 August 2021 08:00Ziccum AB (publ) releases Q2 Report 2021
(Lund, Sweden, 26 August 2021) Ziccum AB today releases its Q2 Report for 2021. For the first time the Report will also be released in a digital online format allowing subscribers and readers to more easily interact with and navigate every aspect of the...
26 August 2021 08:00Ziccum AB (publ) publicerar delårsrapport för andra kvartalet 2021
(Lund, Sverige, 26 augusti 2021) Ziccum AB meddelar att bolagets Q2-rapport för 2021 nu är tillgänglig. För första gången kommer rapporten också att släppas i ett digitalt onlineformat som gör det enklare...
30 June 2021 08:30ZICCUM AB: Andreas Pettersson, Senior Director of Corporate Finance at Northvolt, on being Ziccum's new Board member
As Senior Director of Corporate Finance at Northvolt AB, a leading innovator in sustainable lithium ion battery production, Andreas Pettersson, Ziccum’s new Board member, is no stranger to disruptive technologies: “Disruption always meet resistance...
21 May 2021 08:30Optionsinnehavare i Ziccum utnyttjar samtliga teckningsoptioner i incitamentsprogrammet 2018/2021
Den 25 april 2018 beslutade årsstämman i Ziccum AB (publ) (”Ziccum” eller ”Bolaget”) att emittera 200 000 teckningsoptioner till styrelsens fyra ledamöter inom ramen för ett teckningsoptionsprogram (”LTI...
19 May 2021 08:25ZICCUM AB welcomes urgent calls to ramp up vaccine manufacturing across the globe to address inequity in vaccine access and prevent future pandemics
Last week saw repeated calls from influential global stakeholders to establish or upgrade vaccine manufacturing facilities, particularly those in low- and middle- income countries (LMICs). Ziccum CEO: “We welcome these important developments and...
14 May 2021 08:30Ziccums incitamensprogram fulltecknade
Den 27 april 2021 beslutade årsstämman i Ziccum AB (publ) (”Ziccum” eller ”Bolaget”), efter förslag från styrelsen respektive valberedningen, att anta ett långsiktigt incitamentsprogram för styrelseledamöter...
28 April 2021 08:30Ziccum AB: ‘Thermostable dry powder vaccines can play a key role in six UN Sustainable Development Goals’ – CFO
Ziccum AB is now integrating the UN’s Sustainable Development Goals (SDGs) into every aspect of its industrial and business strategy. CFO Frida Hjelmberg: “We have identified that our regional Fill and Finish plants formulating thermostable...
27 April 2021 13:17Kommuniké från årsstämma i Ziccum AB (publ)
Ziccum AB (publ) (”Ziccum”) avhöll den 27 april 2021 årsstämma. Med anledning av rådande covid-19-pandemi hölls årsstämman endast genom poströstning. Vid stämman fattades bland annat följande...
23 April 2021 08:45ZICCUM AB Interim Report January 1-March 31, 2021
Summary of interim report, first quarter 2021 Ziccum has announced its goals for 2021, the main goals are to enter into a first licensing agreement for one or more vaccines and to present a detailed plan to establish a production facility for filling...
23 April 2021 08:45ZICCUM AB Delårsrapport 1 januari-31 mars 2021
Sammanfattning av delårsrapporten - första kvartalet 2021 Ziccum har offentligjort sina mål för 2021, huvudmålen är att ingå ett första licensavtal avseende ett eller flera vacciner samt att presentera en detaljerad...
21 April 2021 09:02ZICCUM AB supports World Immunization Week with new initiatives highlighting regional Fill and Finish plants
Ziccum AB is actively supporting the WHO’s World Immunization Week 2021, this year with the theme ‘Vaccines Bring us Closer’. CEO Göran Conradson: “We’ll be attending meetings and policy events with vaccine bodies from...
19 April 2021 08:25ZICCUM AB supports historic new CEPI and African Union agreement to enhance vaccine manufacturing and R&D in Africa
A ground-breaking new memorandum of understanding between CEPI (The Coalition for Epidemic Preparedness Innovations) and the African Union was signed following a prestigious two-day virtual event, attended by Ziccum, hosted by the Africa Centres for Disease...
26 March 2021 11:50MAPPING THE FLOW: Industrial process specialist models Ziccum dry powder vaccine methodology
Dr Anton Löfgren is an industrial process engineer specialising in unit operations in pharma manufacturing. For four months he visited Ziccum to develop mathematical models of Ziccum’s LaminarPace vaccine air-drying methodology for future industrial...
24 March 2021 08:15KALLELSE TILL ÅRSSTÄMMA I ZICCUM AB (PUBL)
Aktieägarna i Ziccum AB (publ), org.nr 559107-9412, kallas härmed till årsstämma den 27 april 2021. Mot bakgrund av den extraordinära situation som råder till följd av covid-19-pandemin kommer Ziccum AB:s årsstämma...
23 March 2021 08:15ZICCUM AB releases Annual Report for 2020
(Lund, Sweden, 23 March 2021) Ziccum AB today announces that its Annual Report for 2020 is now available on the company’s website. For further information and to read the Full Report (in Swedish) please visit:: https://ziccum.com/investors/financial-reports/...
23 March 2021 08:15Ziccum publicerar årsredovisning för 2020
(Lund, sverige mars 23, 2021) Ziccum AB meddelar att bolagets årsredosvisning för 2020 nu finns tillgänglig på bolagets hemsida. För mer information vänligen besök: https://ziccum.com/investors/financial-reports/ Pressmeddelandet...
17 March 2021 14:25ZICCUM AB accepted as member of NIIMBL - prestigious US biopharma innovation group
Swedish vaccine innovation company ZICCUM AB has been accepted as a member of NIIMBL, the US National Institute for Innovation in Manufacturing Biopharmaceuticals. NIIMBL drives innovation and uptake of new technologies within biopharmaceutical manufacturing...
16 March 2021 09:05ZICCUM welcomes new 3.5 BUSD vaccine initiative from CEPI with special focus on vaccine manufacturing
“We welcome CEPI’s new global initiative to prepare for future pandemics” says Ziccum CEO Göran Conradson, “and in particular its commitment to providing significant funding towards new manufacturing innovation to help scale-up...
12 March 2021 14:23ZICCUM AB on global vaccine summit: “Fill and Finish focus welcome, now let’s really collaborate”
A major two-day summit of the world's top pharma and public health sector players has ended with strong agreement that scale-up of vaccine manufacturing is an urgent priority for 2021 and 2022. The summit held on 8-9 March 2021 and accompanying landscape...